Biocure Technology Inc. (BICTF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0086 (614.29%)
At close: May 14, 2025

Biocure Technology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
10111122
Market Cap Growth
-96.06%-89.80%32.67%-92.65%-49.21%34.20%
Enterprise Value
10121324
Last Close Price
0.010.630.630.140.931.48
PB Ratio
0.520.120.88-0.47-16.26-11.87
P/TBV Ratio
0.520.120.88---
P/FCF Ratio
-11.42----
P/OCF Ratio
-11.42----
EV/FCF Ratio
-12.94----
Debt / Equity Ratio
0.040.040.03-0.04-4.45-1.72
Debt / FCF Ratio
-3.62----
Net Debt / Equity Ratio
0.000.020.02-0.02-4.26-1.70
Net Debt / EBITDA Ratio
----0.06-2.17-1.30
Net Debt / FCF Ratio
-0.082.31-0.17-0.05-3.35-3.00
Quick Ratio
0.140.040.030.010.050.03
Current Ratio
0.150.040.030.030.570.03
Return on Equity (ROE)
-18.02%-17.83%----
Return on Assets (ROA)
-7.49%-10.03%-32.40%-13.50%-24.91%-42.01%
Return on Capital Employed (ROCE)
-14.50%-22.90%-64.00%28.90%-432.10%-503.30%
Earnings Yield
-34.17%-167.53%-128.63%-133.13%-8.14%-10.72%
FCF Yield
-8.75%-15.40%-75.83%-7.82%-4.78%
Buyback Yield / Dilution
70.41%-1.23%13.15%-3.76%-4.98%-1.25%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.